J.Molner
Press release from First North

J. Molner Signs Licensing Agreement for Five Approved Drugs in the US

Tallinn, 2023-09-06 08:00 CEST -- Tallinn, Estonia - J. Molner announces a licensing agreement to broaden its reach in the United States. The agreement involves licensing rights for five approved generic topical pharmaceutical products. Molner will lead the effort to reintroduce these products to the US market and will commercialize the products. Molner estimates that the products will be relaunched over the next eighteen months.

         For additional information please contact:
         
         Jason Grenfell-Gardner
         J. Molner AS
         Management Board member
         +372 536 00 346
         jason@jmolner.com